The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech; Genentech (Inst)
CAMMA 3: A multicenter phase Ib trial evaluating the safety, pharmacokinetics, and activity of subcutaneous cevostamab monotherapy in patients with relapsed or refractory multiple myeloma.
 
Sosana Delimpasi
Consulting or Advisory Role - Amgen; Janssen; Takeda
Speakers' Bureau - Amgen; Janssen; Takeda
 
HANG QUACH
Consulting or Advisory Role - Amgen; Antengene; Celgene; CSL Behring; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Sanofi
Research Funding - Amgen; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Michele Cavo
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Roche; Sanofi; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Janssen; Sanofi
 
P. Joy Ho
Research Funding - Abbvie; Amgen; Bristol-Myers Squibb; Crispr Therapeutics; Genentech; Ionis Pharmaceuticals
 
Cindy Lee
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen
Speakers' Bureau - Amgen; Bristol-Myers Squibb
 
Armando Santoro
Consulting or Advisory Role - ARQULE; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Incyte; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; BMS; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Rik Schots
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Celgene
 
Philip Vlummens
No Relationships to Disclose
 
Dok Hyun Yoon
Honoraria - Amgen; Celgene; Celltrion; Janssen; Kirin Pharmaceuticals; Roche; Samyang; Takeda
Consulting or Advisory Role - ABclonal; Amgen; Celgene; GC Pharma; Janssen; Novartis; Roche
Research Funding - ABclonal; Amgen; Boryung; Eutilex; Genmab; Janssen Oncology; Roche/Genentech; Samyang
 
Sung-Soo Yoon
Honoraria - Novartis
Consulting or Advisory Role - Amgen; Celgene/Jazz; Janssen; Takeda
Research Funding - Kyowa Kirin; Roche/Genentech; Yuhan
 
Cedric Dos Santos
Employment - Genentech
Stock and Other Ownership Interests - Amgen
 
Divya Samineni
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche
 
Jiangeng Huang
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Kristin Wehrman
No Relationships to Disclose
 
Upen Patil
No Relationships to Disclose
 
Semira Sheikh
Employment - Roche
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda